Bulk Manufacturer of Controlled Substances Registration, 2578-2579 [2019-01501]
Download as PDF
<![CDATA[
2578
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
a hearing after the ALJ granted the
Government’s Motion for Summary
Disposition and recommended
revocation of Respondent’s registration.
Motion, at 1. The Motion also states
that, as a result of the hearing, the Texas
Medical Board suspended Respondent’s
medical license, ordered that the
suspension be stayed, and placed
Respondent on five years’ probation
under various terms and conditions. Id.
The Motion concludes by stating that,
‘‘Since . . . [Respondent] now has state
authority to handle controlled
substances, the DEA respectfully
request[s] the Administrator to dismiss
the pending Order to Show Cause and
recommended ruling from the
Administrative Law Judge.’’ Id. at 2.
Accordingly, I shall dismiss the Order to
Show Cause.
Order
Pursuant to 28 CFR 0.100(b) and the
authority thus vested in me by 21 U.S.C.
823(f) and 824(a), I order that the Order
to Show Cause issued to Kurt L.
Pflieger, M.D. be, and it hereby is,
dismissed. This Order is effective March
11, 2019.
Dated: January 17, 2019.
Uttam Dhillon,
Acting Administrator.
[FR Doc. 2019–01528 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Chattem Chemicals
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 11, 2019. Such persons
may also file a written request for a
hearing on the application on or before
March 11, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
DATES:
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
31, 2018, Chattem Chemicals Inc., 3801
Saint Elmo Avenue, Chattanooga,
Tennessee 37409–1237 applied to be
registered as an importer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Methamphetamine ...................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................................
Phenylacetone .........................................................................................................................................................................
Opium, raw ..............................................................................................................................................................................
Poppy Straw Concentrate .......................................................................................................................................................
Tapentadol ...............................................................................................................................................................................
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers.
The company plans to import an
intermediate of tapentadol (9780), to
bulk manufacture tapentadol for
distribution to its customers.
DEPARTMENT OF JUSTICE
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
ACTION:
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
Notice of registration.
Registrants listed below have
applied for and been granted a
registration by the Drug Enforcement
Administration (DEA) as bulk
SUMMARY:
[FR Doc. 2019–01512 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
The
companies listed below applied to be
registered as bulk manufacturers of
various basic classes of controlled
substances. Information on previously
published notices are listed in the table
below. No comments or objections were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
FR
Docket
National Center for Natural Products Research NIDA MPROJECT ............................................................
Halo Pharmaceutical, Inc ..............................................................................................................................
Nanosyn, Inc .................................................................................................................................................
83 FR 48334
83 FR 48334
83 FR 48867
17:23 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
manufacturers of various classes of
schedule I and II controlled substances.
Company
VerDate Sep<11>2014
1105
8333
8501
9600
9670
9780
Schedule
E:\FR\FM\07FEN1.SGM
07FEN1
Published
August 31, 2018.
September 24, 2018.
September 27, 2018.
2579
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed companies.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule II controlled substances.
[FR Doc. 2019–01501 Filed 2–6–19; 8:45 am]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
SUMMARY:
The
company listed below applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on a previously
published notice is listed below. No
comments or objections were submitted
for the notice.
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
Company
FR Docket
Published
Janssen Pharmaceuticals, Inc ..........................................................................................................................
83 FR 55205
November 2, 2018.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: January 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01502 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Kinetochem,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 8, 2019.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
17, 2018, Kinetochem, LLC., 111 W
Cooperative Way, Ste. 310–B,
Georgetown, Texas 78626 applied to be
registered as a bulk manufacturer for the
basic classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled
substance
DATES:
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
Marihuana .................
PO 00000
Frm 00093
Fmt 4703
Drug
code
7360
Sfmt 4703
Schedule
I
Controlled
substance
Tetrahydrocannabinols.
Drug
code
7370
Schedule
I
The company plans to manufacture
drug codes 7360 (marihuana) and 7370
(tetrahydrocannabinols), in bulk for
distribution and sale to its customers.
The company plans to synthetically
manufacture these drugs. No other
activities for these drug codes are
authorized for this registration.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01509 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Pharmaceutical Materials, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 8, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2578-2579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01501]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted a
registration by the Drug Enforcement Administration (DEA) as bulk
manufacturers of various classes of schedule I and II controlled
substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as bulk manufacturers of various basic classes of controlled
substances. Information on previously published notices are listed in
the table below. No comments or objections were submitted for these
notices.
----------------------------------------------------------------------------------------------------------------
Company FR Docket Published
----------------------------------------------------------------------------------------------------------------
National Center for Natural Products 83 FR 48334 August 31, 2018.
Research NIDA MPROJECT.
Halo Pharmaceutical, Inc................. 83 FR 48334 September 24, 2018.
Nanosyn, Inc............................. 83 FR 48867 September 27, 2018.
----------------------------------------------------------------------------------------------------------------
[[Page 2579]]
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of these registrants to manufacture
the applicable basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each of the company's maintenance of
effective controls against diversion by inspecting and testing each
company's physical security systems, verifying each company's
compliance with state and local laws, and reviewing each company's
background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed companies.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01501 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P
